Cargando…

Diabetes Epidemiology in the COVID-19 Pandemic

Diabetes has been identified as an important risk factor for mortality and rates of progression to acute respiratory distress syndrome (ARDS) in hospitalized patients with coronavirus disease 2019 (COVID-19). However, many recent reports on this topic reflect hurried approaches and have lacked caref...

Descripción completa

Detalles Bibliográficos
Autores principales: Selvin, Elizabeth, Juraschek, Stephen P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7372044/
https://www.ncbi.nlm.nih.gov/pubmed/32540920
http://dx.doi.org/10.2337/dc20-1295
_version_ 1783561232781934592
author Selvin, Elizabeth
Juraschek, Stephen P.
author_facet Selvin, Elizabeth
Juraschek, Stephen P.
author_sort Selvin, Elizabeth
collection PubMed
description Diabetes has been identified as an important risk factor for mortality and rates of progression to acute respiratory distress syndrome (ARDS) in hospitalized patients with coronavirus disease 2019 (COVID-19). However, many recent reports on this topic reflect hurried approaches and have lacked careful epidemiologic design, conduct, and analysis. Features of prior studies have posed problems for our understanding of the true contribution of diabetes and other underlying comorbidities to prognosis in COVID-19. In this Perspective, we discuss some of the challenges of interpreting the current literature on diabetes and COVID-19 and discuss opportunities for future epidemiologic studies. We contend that the COVID-19 pandemic is a defining moment for the field of epidemiology and that diabetes epidemiology should play a significant role.
format Online
Article
Text
id pubmed-7372044
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher American Diabetes Association
record_format MEDLINE/PubMed
spelling pubmed-73720442021-08-01 Diabetes Epidemiology in the COVID-19 Pandemic Selvin, Elizabeth Juraschek, Stephen P. Diabetes Care Diabetes and COVID-19: Tactics for Study and Management Diabetes has been identified as an important risk factor for mortality and rates of progression to acute respiratory distress syndrome (ARDS) in hospitalized patients with coronavirus disease 2019 (COVID-19). However, many recent reports on this topic reflect hurried approaches and have lacked careful epidemiologic design, conduct, and analysis. Features of prior studies have posed problems for our understanding of the true contribution of diabetes and other underlying comorbidities to prognosis in COVID-19. In this Perspective, we discuss some of the challenges of interpreting the current literature on diabetes and COVID-19 and discuss opportunities for future epidemiologic studies. We contend that the COVID-19 pandemic is a defining moment for the field of epidemiology and that diabetes epidemiology should play a significant role. American Diabetes Association 2020-08 2020-06-15 /pmc/articles/PMC7372044/ /pubmed/32540920 http://dx.doi.org/10.2337/dc20-1295 Text en © 2020 by the American Diabetes Association https://www.diabetesjournals.org/content/licenseReaders may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at https://www.diabetesjournals.org/content/license.
spellingShingle Diabetes and COVID-19: Tactics for Study and Management
Selvin, Elizabeth
Juraschek, Stephen P.
Diabetes Epidemiology in the COVID-19 Pandemic
title Diabetes Epidemiology in the COVID-19 Pandemic
title_full Diabetes Epidemiology in the COVID-19 Pandemic
title_fullStr Diabetes Epidemiology in the COVID-19 Pandemic
title_full_unstemmed Diabetes Epidemiology in the COVID-19 Pandemic
title_short Diabetes Epidemiology in the COVID-19 Pandemic
title_sort diabetes epidemiology in the covid-19 pandemic
topic Diabetes and COVID-19: Tactics for Study and Management
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7372044/
https://www.ncbi.nlm.nih.gov/pubmed/32540920
http://dx.doi.org/10.2337/dc20-1295
work_keys_str_mv AT selvinelizabeth diabetesepidemiologyinthecovid19pandemic
AT juraschekstephenp diabetesepidemiologyinthecovid19pandemic